Penn effort to expand trials of olaparib leads to new treatment options for patients with advanced BRCA-related breast cancer
Credit: Penn Medicine CHICAGO -- Six years ago an international team of physician scientists known as BRCA-TAC led a charge to advance clinical testing of...


